COMP Human

Cartilage Oligomeric Matrix Protein Human Recombinant
Shipped with Ice Packs
In Stock

Description

Key Compound Classes in Human Studies

Human-centric compound research focuses on:

  • Radiolabelled compounds (e.g., ¹⁴C-labeled molecules) for tracking absorption, metabolism, and excretion (AME) .

  • Immunomodulatory compounds like AH10-7, which selectively activate tumor-fighting invariant natural killer T (iNKT) cells .

  • Small-molecule therapeutics analyzed via AI models (e.g., CODE-AE) for efficacy prediction .

Human AME Study Designs

Absorption, Metabolism, Excretion (AME) studies use radiolabelled compounds to evaluate drug behavior:

Study TypeRadioactivity DoseKey Objectives
Low-dose microtracer1–5 µCiMass balance, metabolite profiling
High-dose macrotracer100–200 µCiAbsolute bioavailability, IVPK
Phase 0 microdose (eIND)<1 µCiEarly PK/excretion profiling

Outputs: Metabolite proportions, biotransformation pathways, and high-resolution MS/MS spectra .

Regulatory and Analytical Frameworks

  • Guidelines: FDA MIST, ICH M3(R2), and EMA DDI dictate metabolite safety thresholds (>10% AUC of total drug-related material) .

  • Technologies: Accelerator Mass Spectrometry (AMS) enables ultra-sensitive detection of ¹⁴C compounds in biological matrices .

AH10-7 (iNKT Cell Activator)

  • Mechanism: Hydrocinnamoyl ester modification enhances stability and Th1 cytokine bias, improving antitumor response .

  • Efficacy: Suppressed melanoma growth in humanized mice at levels comparable to benchmark ligand KRN7000 .

CODE-AE AI Model

  • Function: Predicts human responses to novel compounds using genomic and structural data .

  • Performance: Identified personalized drugs for >9,000 patients in theoretical tests .

Challenges in Compound Optimization

  • Cytotoxicity Prediction: Current models show modest accuracy (Pearson’s r < 0.28 for individual responses) but improve for population-level predictions (r < 0.66) .

  • Metabolite Safety: Human-specific metabolites not observed in animal models require early AME studies to mitigate toxicity risks .

Future Directions

  • Pangenome Integration: Enhanced genomic diversity data (e.g., Human Pangenome Reference Consortium) may refine compound safety/efficacy predictions .

  • Hybrid AMS-LSC Analysis: Combines liquid scintillation counting (LSC) for early timepoints and AMS for prolonged tracking .

Product Specs

Introduction

COMP, a large glycoprotein, plays a crucial role in cartilage health. As a member of the thrombospondin family, this non-collagenous protein is found abundantly in the extracellular matrix of various cartilaginous tissues like articular, nasal, and tracheal cartilage. Its presence extends to other tissues such as synovium and tendon. COMP forms a pentameric structure, with each subunit contributing to its high molecular weight exceeding 500kDa. This protein exhibits calcium-binding properties. The carboxy-terminal globular domain of COMP interacts with collagen types I, II, and IX, highlighting its importance in maintaining the structural integrity and characteristics of the collagen network. Additionally, COMP serves as a reservoir and transporter for signaling molecules like vitamin D. Genetic mutations affecting COMP are linked to skeletal disorders like Pseudoachondroplasia and certain types of multiple epiphyseal dysplasia, emphasizing its crucial role in skeletal development and function.

Description

Recombinant human COMP, produced in HEK293 cells, is a single polypeptide chain that has been glycosylated. This protein consists of 749 amino acids (specifically, residues 21 to 757), resulting in a molecular weight of 82.4kDa. To facilitate purification, a 6-amino acid His tag is attached to the C-terminus. The purification process utilizes proprietary chromatographic methods to ensure high purity.

Physical Appearance

The appearance of the solution is a clear and colorless liquid that has been sterilized by filtration.

Formulation

The COMP solution is provided at a concentration of 0.5mg/ml and is prepared in a phosphate buffered saline solution (pH 7.4) containing 10% glycerol.

Stability

For short-term storage (up to 2-4 weeks), the COMP solution should be stored at a refrigerated temperature of 4°C. For extended storage, it is recommended to store the solution in a frozen state at -20°C. To further enhance stability during long-term storage, the addition of a carrier protein like HSA or BSA (at a concentration of 0.1%) is advisable. To maintain the quality of the protein, it is crucial to minimize the number of freeze-thaw cycles.

Purity

The purity of this product is determined using SDS-PAGE analysis and is guaranteed to be greater than 85.0%.

Synonyms

Cartilage Oligomeric Matrix Protein (pseudoachondroplasia epiphyseal dysplasia 1 multiple), MED, THBS5, TSP5, EDM1, PSACH, EPD1, Thrombospondin-5

Source

HEK293 Cells.

Amino Acid Sequence

ADPDAHSLWY NFTIIHLPRH GQQWCEVQSQ VDQKNFLSYD CGSDKVLSMG HLEEQLYATD AWGKQLEMLR EVGQRLRLEL ADTELEDFTP SGPLTLQVRM SCECEADGYI RGSWQFSFDG RKFLLFDSNN RKWTVVHAGA RRMKEKWEKD SGLTTFFKMV SMRDCKSWLR DFLMHRKKRL EPTAPPTMAP GLEPKSCDKT HTCPPCPAPE LLGGPSVFLF PPKPKDTLMI SRTPEVTCVV VDVSHEDPEV KFNWYVDGVE VHNAKTKPRE EQYNSTYRVV SVLTVLHQDW LNGKEYKCKV SNKALPAPIE KTISKAKGQP REPQVYTLPP SRDELTKNQV SLTCLVKGFY PSDIAVEWES NGQPENNYKT TPPVLDSDGS FFLYSKLTVD KSRWQQGNVF SCSVMHEALH NHYTQKSLSL SPGKHHHHHH

Q&A

What is the standard experimental design flow for human subject research in computational fields?

Computational human research follows a structured experimental design flow to ensure scientific rigor. The process typically involves:

  • Formulating a clear research question

  • Developing testable hypotheses

  • Identifying independent, dependent, and control variables

  • Determining appropriate experimental design structure

  • Calculating required sample size for statistical power

  • Implementing random assignment and selection

  • Executing the experiment with data collection

  • Analyzing collected data with appropriate statistical methods

  • Interpreting findings and drawing inferences

  • Documenting and reporting results comprehensively

This methodical approach ensures that human subject research maintains integrity through principles of replication, randomization, control, and blocking . Replication verifies reliability, randomization prevents bias, control groups provide comparative baselines, and blocking accounts for participant characteristics that might influence outcomes .

How should researchers classify variables when designing human-computer interaction studies?

When designing HCI studies, researchers must carefully classify variables to ensure methodological clarity:

Variable TypeDefinitionExamples in HCI Research
IndependentVariables manipulated by researchersInterface design, information presentation methods, interaction modalities
DependentOutcome measurementsTask completion time, error rates, user satisfaction scores
ControlVariables held constantEnvironment conditions, task instructions, hardware specifications
ConfoundingVariables that may influence results if not controlledPrior experience, age, cognitive abilities
BlockingVariables used to group participantsExpertise level, demographic factors, cognitive traits

Proper variable classification is essential for valid hypothesis testing. For complex HCI studies, researchers should consider mixed-method approaches that balance quantitative measurements with qualitative insights to capture the multidimensional nature of human-computer interaction . This approach helps address the challenge that human responses often involve both measurable performance metrics and subjective experience factors.

What are the fundamental principles for collecting valid human subject data in computational research?

Valid human subject data collection requires adherence to several fundamental principles:

  • Systematic Investigation: Research must follow structured protocols that incorporate both data collection and analysis methods designed to answer specific questions .

  • Appropriate Sampling: Sample selection should represent the target population while accounting for practical constraints. Sample size calculations should be performed to ensure adequate statistical power .

  • Standardized Procedures: All participants should experience consistent experimental conditions with standardized instructions and procedures to minimize unintended variability .

  • Ethical Considerations: Research must prioritize participant welfare through informed consent, risk minimization, and privacy protection as defined by institutional review boards and relevant regulations .

  • Measurement Validity: Data collection instruments must accurately measure what they purport to measure, whether they are surveys, behavioral observations, or physiological recordings .

  • Rigorous Documentation: Detailed records of all procedures, unexpected events, and methodological decisions enable transparency and replicability .

The HHS defines human subject research as involving living individuals from whom researchers obtain data through intervention/interaction or identifiable private information . This definition guides methodological decisions throughout the research process.

How can researchers effectively incorporate both quantitative and qualitative methods in human-computer studies?

Effective mixed-method approaches in HCI research require strategic integration:

  • Sequential Design: Begin with one method and use findings to inform the other. For example, conduct qualitative interviews to develop hypotheses, then test them quantitatively via controlled experiments .

  • Concurrent Design: Collect both types of data simultaneously, allowing triangulation of findings. This approach provides complementary perspectives on the same research questions .

  • Data Transformation: Convert qualitative data to quantitative (quantitization) or interpret quantitative results through qualitative lenses (qualitization) to enhance analytical depth .

  • Integration Points:

    • Design phase: Use mixed methods to develop more robust research questions

    • Collection phase: Gather complementary data types simultaneously

    • Analysis phase: Cross-validate findings between methods

    • Interpretation phase: Develop more comprehensive explanations

How should researchers address contradictions in dialogue modeling and human-machine interaction data?

Contradictions in dialogue modeling and human-machine interaction data present significant analytical challenges requiring sophisticated approaches:

  • Structured vs. Unstructured Analysis: Research indicates that structured approaches—where utterances are paired separately before processing—often outperform unstructured approaches where concatenated dialogues are analyzed as a whole. This structured method explicitly accounts for natural dialogue patterns and relation-specific contradictions .

  • Contradiction Types Taxonomy: Develop a classification system for contradiction types that distinguishes between:

    • Self-contradictions (within single agent utterances)

    • Cross-turn contradictions (between turns in a conversation)

    • Contextual contradictions (between utterance and contextual knowledge)

    • Temporal contradictions (statements contradicting earlier factual assertions)

  • Out-of-Distribution Testing: Include human-labeled contradictions from diverse dialogue settings, particularly human-bot interactions, to evaluate model robustness beyond training distributions .

  • Natural Language Inference (NLI) Models: Advanced research employs specialized NLI models trained to detect contradictions within dialogue structures rather than relying on general language models. These approaches typically require specialized training data containing both human-human and human-bot contradictory dialogues .

For researchers dealing with human-machine dialogue data, validation across multiple dialogue contexts is essential, as contradiction patterns differ significantly between human-human conversations and human-machine interactions .

What methodologies exist for predicting human population responses to toxic compounds in computational toxicology?

Computational prediction of human responses to toxic compounds represents a frontier in predictive toxicology, with several methodological approaches:

  • Population-Based Genomic Prediction: Studies have demonstrated that while individual-level cytotoxicity predictions remain challenging (Pearson's r < 0.28), population-level response predictions can achieve higher correlations (r < 0.66). This difference highlights the complexity of individual-specific genetic factors versus general toxicity mechanisms .

  • Integrated Predictive Approaches:

ApproachData SourcesStrengthsLimitations
Structure-BasedCompound structural attributesRequires no biological testingMay miss biological mechanisms
Genomic Profile-BasedIndividual genotype & transcriptomic dataPerson-specific predictionsModest individual prediction accuracy
Hybrid ModelsCombined structural and genomic dataImproved predictive powerComputational complexity
Population-Average ModelsAggregated cytotoxicity dataBetter generalizabilityLacks individual specificity
  • Validation Methodologies: To establish reliability, predictions must be evaluated against blinded experimental datasets with diverse compounds and genetic profiles. The Tox21 1000 Genomes Project provides valuable validation resources, measuring cytotoxicity of compounds across hundreds of cell lines with known genetic profiles .

This research area demonstrates the potential for predicting population health risks from unknown compounds, though individual-level prediction accuracy remains suboptimal due to the complex genetic determinants of toxic response variation .

What are the most effective experimental designs for detecting individual differences in human-computer interaction?

Detecting individual differences in HCI requires specialized experimental designs that balance internal validity with sensitivity to variation:

  • Within-Subject Factorial Designs: These designs offer superior power for detecting individual differences by controlling for person-specific variance. Each participant experiences multiple experimental conditions, allowing researchers to isolate interaction effects between individual traits and interface variables .

  • Adaptive Testing Protocols: Dynamic adjustment of task difficulty or interface parameters based on individual performance characteristics can reveal differences that fixed designs might obscure .

  • Individual Differences Blocking: Stratifying participants based on theoretically relevant characteristics (cognitive abilities, expertise, personality traits) before random assignment improves detection of attribute-specific interaction patterns .

  • Mixed-Effects Modeling Approaches: Statistical techniques that incorporate both fixed effects (experimental manipulations) and random effects (individual variation) provide powerful tools for quantifying individual difference components .

The Computer-Aided Design Reference for Experiments (CADRE) tool offers researchers specialized guidance for human factors experimental design that accommodates individual difference analysis . Modern approaches emphasize that capturing individual differences requires larger sample sizes than traditional experiments, with power analyses specifically accounting for expected interaction effect sizes .

How can researchers effectively implement human Absorption, Metabolism, and Excretion (AME) studies in computational modeling?

Human AME studies provide critical data for computational modeling of drug pharmacokinetics and require specialized methodological approaches:

  • Integrated Radiolabeled Sciences Approach: Comprehensive human AME studies utilize 14C radiolabeled compounds to track absorption, metabolism, and excretion processes with high precision. The methodological workflow integrates:

    • Radiosynthesis of test compounds

    • Preclinical ADME studies

    • Human dosimetry calculations

    • 14C dose formulation

    • Radio-analysis including Accelerator Mass Spectrometry (AMS)

  • Micro vs. Macro Tracer Methodologies:

Protocol TypeRadioactive DoseAnalysis MethodApplications
Low 14C (Micro Tracer)~1-5 μCi with therapeutic doseAMSReduced radiation exposure, suitable for most AME studies
High 14C (Macro Tracer)~100-200 μCi with therapeutic doseLiquid Scintillation Counting (LSC)Higher sensitivity for certain metabolites
Hybrid DesignVariableLSC for early timepoints, AMS for laterOptimized sensitivity across timepoints
  • Computational Integration: Modern approaches use these experimental data to develop physiologically-based pharmacokinetic (PBPK) models that predict compound behavior in diverse human populations. Effective implementation requires:

    • Integration of in vitro and clinical data

    • Population pharmacokinetic modeling

    • Sensitivity analysis for key parameters

    • Cross-validation against independent datasets

Phase 0 microdose studies under exploratory investigational new drug (eIND) applications provide early-stage evaluation of pharmacokinetics and excretion patterns, generating valuable data for initial computational model development with minimal human exposure .

How should researchers leverage Google's People Also Ask data to identify critical research questions in computational human studies?

Google's People Also Ask (PAA) feature represents an underutilized resource for identifying research priorities and knowledge gaps in computational human research:

  • Systematic Question Extraction: Researchers should implement a structured approach to extracting PAA data:

    • Perform seed searches with domain-specific terminology

    • Document all PAA questions that appear (they cascade as users click)

    • Classify questions by research domain and complexity

    • Identify frequently recurring questions across multiple search variations

  • Intent Analysis Framework: PAA data reveals underlying search intent patterns that can inform research priorities:

    • Informational questions indicate knowledge gaps

    • Comparative questions highlight competing methodologies

    • Procedural questions suggest practical implementation challenges

    • Causal questions point to mechanistic understanding needs

  • Temporal Monitoring: PAA questions change over time, reflecting evolving research interests and knowledge gaps. Regular monitoring provides insights into emerging research directions and changing priorities within the field .

  • Content Strategy Alignment: Research programs can gain relevance by addressing the questions most frequently asked by the scientific community and stakeholders, as reflected in PAA data .

PAA features appear in over 80% of English searches, generally within the first few results, making them a widespread indicator of information needs. For computational human research specifically, tracking these questions helps identify where methodological uncertainty or controversy exists in the field .

What are the best practices for designing experiments involving human-machine dialogue and addressing potential contradictions?

Designing experiments for human-machine dialogue requires specialized methodological considerations:

  • Contradiction-Aware Experimental Design:

    • Include deliberate contradiction opportunities to test system robustness

    • Balance between scripted and open-ended interactions

    • Incorporate multi-turn dialogue sequences that reference previous statements

    • Include evaluation metrics specifically for contradiction detection

  • Dialogue Data Collection Protocol:

PhaseKey ConsiderationsImplementation Notes
PreparationDefine contradiction taxonomiesClassify by type, severity, and intentionality
Participant SelectionDiverse demographic samplingInclude both expert and naive users
Task DesignBalance directive vs. exploratory tasksProvide scenarios that naturally elicit complex dialogues
RecordingCapture full context including non-verbal cuesEnsure time-synchronized multimodal data
AnnotationMulti-rater contradiction labelingCalculate inter-rater reliability metrics

Research indicates that contradictions in human-bot dialogues differ qualitatively from those in human-human interactions, necessitating specialized evaluation frameworks and testing environments .

How can researchers effectively integrate computational prediction models with human subject experimental data?

Integration of computational prediction models with human subject data requires methodological rigor to maintain validity:

  • Bidirectional Integration Framework:

Integration DirectionMethodologyApplications
Model → ExperimentUse model predictions to inform experimental designPrioritize conditions, optimize sampling, focus hypotheses
Experiment → ModelRefine models based on experimental findingsParameter adjustment, architecture refinement, feature selection
Iterative CycleAlternate between modeling and experimentationProgressive refinement, targeted exploration of discrepancies
  • Cross-Validation Strategies:

    • Hold-out validation: Reserve portion of human data for final validation

    • K-fold cross-validation: Systematically test model on different data subsets

    • Leave-one-subject-out: Validate generalizability across individuals

    • Transfer validation: Test on different experimental conditions or populations

  • Integration Challenges and Solutions:

    • Scale mismatch: Develop normalization approaches for model and human data

    • Temporal alignment: Implement time-warping algorithms for dynamic processes

    • Individual variability: Incorporate individual-specific parameters in models

    • Uncertainty representation: Propagate uncertainty from both sources through integration

Research on human population responses to toxic compounds demonstrates this integration approach, where computational predictions of cytotoxicity were systematically compared with experimental measurements across 884 lymphoblastoid cell lines, revealing stronger performance for population-level predictions (r < 0.66) than individual-level predictions (r < 0.28) .

What are the key ethical requirements for computational research involving human subjects?

Computational research with human subjects must adhere to specific ethical requirements:

  • Regulatory Framework: Human subject research is governed by institutional review boards (IRBs) operating under regulatory frameworks such as HHS regulations (45 CFR 46.102), which define human subjects as living individuals about whom researchers obtain data through intervention/interaction or identifiable private information .

  • Core Ethical Requirements:

RequirementImplementation in Computational ResearchRegulatory Basis
Informed ConsentClear disclosure of data collection, processing, and potential risksRespect for persons principle
Risk MinimizationData security protocols, privacy protections, psychological safeguardsBeneficence principle
Justice in Subject SelectionRepresentative sampling, inclusion of diverse populationsJustice principle
Scientific ValidityMethodological rigor, appropriate sample sizes, valid analysis methodsResearch ethics codes
Privacy and ConfidentialityData anonymization, secure storage, restricted access protocolsData protection regulations
  • Special Considerations for Computational Methods:

    • Algorithm transparency: Participants should understand how their data will be processed

    • Secondary data use: Restrictions on repurposing collected data for other analyses

    • Data retention: Clear policies on storage duration and eventual destruction

    • Re-identification risks: Assessment of potential for anonymous data to become identifying through combination with other datasets

Computational research involving vulnerable populations (children, cognitively impaired individuals, etc.) requires additional protections and specialized consent procedures as outlined in research ethics guidelines .

What methodological approaches help ensure diverse representation in human-computer interaction studies?

Ensuring diverse representation in HCI research requires intentional methodological approaches:

  • Sampling Strategy Framework:

    • Population-based sampling with demographic stratification

    • Purposive sampling to ensure inclusion of underrepresented groups

    • Community-based participatory approaches for culturally-sensitive research

    • Adaptive sampling that adjusts recruitment based on initial participation patterns

  • Inclusive Research Design Considerations:

    • Accessibility accommodations for participants with disabilities

    • Cultural sensitivity in task design and instructions

    • Multilingual materials and support when appropriate

    • Flexible scheduling and participation options

    • Compensation structures that don't create undue barriers

  • Analysis Approaches for Diversity:

    • Disaggregated analysis by relevant demographic factors

    • Intersectional analysis examining combined factors

    • Mixed-methods approaches incorporating qualitative experiences

    • Testing for differential item functioning or measurement invariance across groups

Recent advancements in HCI research methodologies emphasize the importance of conducting research with diverse populations including children, older adults, and individuals with cognitive impairments, requiring specialized approaches tailored to these groups' needs and capabilities .

What are the methodological best practices for handling data privacy in computational human research?

Data privacy in computational human research requires robust methodological protections:

  • Privacy-Preserving Research Design:

    • Collect only necessary data (data minimization principle)

    • De-identification at the earliest possible stage

    • Use synthetic data for algorithm development when possible

    • Implement privacy-by-design principles throughout research workflow

  • Technical Protection Measures:

TechniqueImplementationPrivacy Benefit
Differential PrivacyAdd calibrated noise to data or resultsPrevents individual identification while preserving aggregate insights
Federated LearningProcess data locally without central collectionRaw data remains under subject control
Secure Multi-Party ComputationCollaborative computation without sharing raw dataEnables analysis across institutions without data transfer
Homomorphic EncryptionCompute on encrypted dataAllows processing without exposure of raw information
  • Consent and Control Mechanisms:

    • Granular consent options for different data types and uses

    • Dynamic consent platforms allowing participants to modify permissions

    • Clear data retention policies and deletion procedures

    • Transparent processes for handling incidental findings

  • Documentation and Accountability:

    • Comprehensive data management plans

    • Regular privacy impact assessments

    • Audit trails for all data access and processing

    • Independent oversight of privacy protection implementation

These practices align with regulatory requirements while addressing the unique challenges of computational methods that may identify patterns in seemingly anonymous data that could lead to re-identification of research participants .

Product Science Overview

Structure and Composition

COMP is a large, pentameric glycoprotein with a molecular weight of approximately 550 kDa. It belongs to the thrombospondin gene family and is characterized by its disulfide-linked structure. The protein contains several domains, including epidermal growth factor-like repeats and calcium-binding repeats, which are essential for its function .

Biological Function

COMP is primarily involved in the assembly and stabilization of the extracellular matrix in cartilage. It binds to various matrix components, including collagen types I, II, and IX, and matrilins . This binding capability is crucial for maintaining the structural integrity of cartilage and facilitating chondrogenesis, the process by which cartilage is formed .

Role in Human Health and Disease

COMP is present during the early stages of human limb development and continues to play a role in maintaining healthy cartilage throughout life . However, its expression is significantly upregulated in conditions such as osteoarthritis (OA) and rheumatoid arthritis (RA) . In OA, COMP is secreted by chondrocytes and is often associated with collagen fibers in the cartilage matrix . Elevated levels of COMP have been detected in the serum and synovial fluid of patients with OA, making it a potential biomarker for the disease .

Human Recombinant COMP

The human recombinant form of COMP is produced using recombinant DNA technology, which involves inserting the COMP gene into a host cell to produce the protein. This recombinant protein is used in various research applications to study its structure, function, and role in diseases. It is also utilized in developing therapeutic strategies for cartilage-related disorders .

Clinical Significance

Due to its involvement in cartilage integrity and disease, COMP has garnered significant interest as a potential therapeutic target. Research has shown that COMP can induce arthritis in animal models, providing insights into the pathogenesis of RA . Additionally, its role as a biomarker for musculoskeletal diseases like knee OA highlights its diagnostic potential .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.